Operator: Good afternoon, and welcome to the Evoke Pharma, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode.

A recent study suggests that GLP-1 receptor agonists (GLP-1RAs) may lower the risk of hematologic cancers, including leukemia ...

An orange a day, regular moderate-to-vigorous exercise, and GLP-1 drugs for diabetes treatment have all been linked to a ...

By screening people for eating disorders and disordered eating before these medications are prescribed, we can prevent unintended consequences.

While headlines scream about America’s $35.5 trillion national debt and President Donald Trump’s drive to “drain the ...

Oprah Winfrey didn't let a little thing like rain get in the way of her workout Friday. The media icon, 71, showcased her fit ...

It seems demand is growing amongst women in perimenopause, menopause and postmenopause looking for multifaceted weight loss ...

SAN DIEGO -- Two retrospective studies hinted at potential negative effects of GLP-1 receptor agonists for patients requiring ...

The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...

Healthy living and weight loss don’t have to be unattainable. ShedRx makes it easy with a combination of GLP-1 medications, ...

Desiree Rodriguez lost 35 pounds on a drug like Ozempic — but the tradeoff was losing “clumps” of her hair. She spoke to The Post about how she managed to minimize the hair loss.

From findings about GLP-1s to spine surgery costs, Becker’s reported on nine key studies in spine and orthopedics since Feb. 13. 1. A study of cervical disc replacements in The Spine Journal found ...